Drug and medical device maker Covidien PLC has completed its $210 million purchase of Aspect Medical Systems, a company that makes brain monitoring technology.
Covidien said its tender offer for Aspect stock, which was worth $12 per share, closed at midnight. Aspect, which is headquartered in Norwood, MA, is now a subsidy of Covidien, which is based in Ireland.
Aspect shares were trading at $7.67 when Covidien made its offer, making the company's bid a 56 percent premium. The stock finished at $12.27 on Friday. In aftermarket trading, Aspect shares fell 20 cents to $12.07, and Covidien stock gave up 11 cents to $43.94.
Latest from Today's Medical Developments
- GrindingHub Americas launches in 2027 in Cincinnati, Ohio
- Methods Machine Tools now offers the Nakamura-Tome NT-Flex
- Battelle awards $900,000 in STEM education grants to Ohio schools
- #55 Lunch + Learn Podcast with KINEXON
- Starrett and Gerstner offer limited edition, American made 1950s replica wooden machinist tool chests
- EMCO’s UNIVERSALTURN 50: The new benchmark in universal turning
- Archetype's Expertise for Equity accelerates early-stage innovation
- Stratasys expands its AM solutions with Tritone's cutting-edge technology
